Immunodiagnostics Market Forecast to 2030 - Global Analysis by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others], Clinical Indication, End User, and Geography

The immunodiagnostics market size is expected to reach US$ 34,487.80 million by 2030 from US$ 19,218.89 million in 2022; it is estimated to record a CAGR of 7.6% from 2022 to 2030.

Immunodiagnostics is referred as a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies specific for a desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy and simplicity of such tests has led to the development of rapid techniques for the diagnosis of disease, microbes and even illegal drugs in vivo.

Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine accurate and faster treatments. A shift from centralized point-of-care testing to decentralized testing has resulted in easy access to these diagnostics. Immunoassay testing helps monitor chronic conditions and detect pathogens, such as bacteria and viruses. Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. The management of infectious diseases can be significantly improved by POCTs, particularly in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits leading to fewer manual errors propel the immunodiagnostics market. Several market players are developing innovative immunodiagnostic products. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, as well as services such as bioconjugation and detection. Further, in September 2020, Roche launched the SARS-CoV-2 Rapid Antigen Test, which is used in POC settings to help healthcare professionals identify the infection within 15 minutes in people suspected of carrying the virus.

In April 2021, DiaSorin introduced the LIAISON IQ, a new immunodiagnostic Point-of-Care (POC) reader, and the LIAISON QuickDetect COVID TrimericS Ab test, developed with Lumos Diagnostics for countries accepting the CE Mark. Using a fingerstick of human capillary blood, this test for the LIAISON IQ identifies specific IgG antibodies against SARS-CoV-2 Spike Protein in 10 minutes.

In April 2021, Chembio Diagnostics, Inc. launched an FDA Emergency Use Authorization-approved, in-licensed rapid point-of-care COVID-19/Flu A&B test for use in traditional and decentralized testing settings. The rapid immunoassay test requires no instrumentation and produces results in 15 minutes.

WHO applauded the test kit developers for efforts taken to innovate and respond to the masses’ requirements during the COVID-19 crisis. According to the American Society for Clinical Pathology, in March 2020, the Cepheid Xpert Xpress SARS-CoV-2 test became the first POC COVID-19 detection assay to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).

Likewise, the use of immunodiagnostics in cancer treatment is increasing. In oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. These advantages and indications are driving the immunodiagnostics market growth.

Based on product, the immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. Based on clinical indication, the market is divided into infectious diseases, Hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. By end user, the immunodiagnostics market is categorized into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. Geographically, the immunodiagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Industrial Biotechnology Leadership Forum (IBLF), International Diabetes Federation (IDF), and Ministry of Health and Prevention (MoHaP) are a few key primary and secondary sources referred to while preparing the report on the immunodiagnostics market.

Based on product, the immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment held the largest immunodiagnostics market share in 2022. The chemiluminescence immunoassays (CLIA) segment is anticipated to record a significant growth rate during the forecast period. Enzyme-linked immunosorbent assay (ELISA) frequently measures antibodies, proteins, antigens, and glycoproteins in biological samples. ELISA is used for HIV diagnosis, pregnancy tests, and cytokine or soluble receptor measurement (from cell supernatant or serum). It has replaced radioimmunoassay (RIA) to become one of the most common and reliable diagnostic tools. Moreover, the ELISA technique advancement led to the development of quantitative PCR, fluorogenic, and electro-chemiluminescent reporters to generate signals. Further, ELISA, along with lateral flow immunoassays, was widely used during the COVID-19 pandemic to identify individuals having antibodies developed against SARS-CoV-2, thus driving the immunodiagnostics market growth.

Immunodiagnostics Market: Competitive Landscape and Key Developments

Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG are a few key companies operating in the immunodiagnostics market. These companies adopt product innovation strategies to meet evolving customer demands, which allows them to maintain their brand name.

A few of the recent developments in the global immunodiagnostics market are mentioned below:

In May 2023, Thermo Fisher Scientific announced that the US FDA had cleared its immunoassays, B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers. These immunoassays assess risks and clinical management of preeclampsia, a severe pregnancy complication.
In April 2023, Thermo Fisher Scientific announced a partnership with ALPCO-GeneProof, a global leader in diagnostics. The partnership has helped to bring TaqPath Menu | GeneProof PCR kits into the market.
In July 2022, Abbott Diagnostics announced its participation in American Association for Clinical Chemistry (AACC) 2022. In the exhibition, the company demonstrated its diagnostics systems and analyzers.
In May 2022, Roche and The Global Fund to Fight AIDS, Tuberculosis and Malaria joined forces to build and strengthen diagnostic capacity and pandemic preparedness in low-and middle-income countries fighting against HIV and tuberculosis (TB).
In September 2022, Mindray launched the ToRCH Panel. With this panel, the company offers high-quality assays to meet different clinical needs. Mindray ToRCH kits support diverse sample types with less quality controls and sample volumes, which ensures great ease and convenience during clinical detection.
In May 2022, Thermo Fisher Scientific announced that the Phadia 2500+ series of instruments are available for autoimmune testing in the US. The family of high-capacity, intuitive lab instruments supplied by Thermo Fisher Scientific, the world leader in serving science, offers reliable and unparalleled high throughput for both allergy diagnostics and autoimmune testing.
In July 2022, Roche announced the launch of the Elecsys HCV Duo immunoassay in countries that accept the CE Mark. The Elecsys HCV Duo immunoassay enables a significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunodiagnostics Market - by Product
1.3.2 Global Immunodiagnostics Market - by Clinical Indication
1.3.3 Global Immunodiagnostics Market - by End User
1.3.4 Global Immunodiagnostics Market - by Geography

2. Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.2.6 South & Central America PEST Analysis
4.3 Expert’s Opinion

5. Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - Global Analysis

6.1 Global Immunodiagnostics Market Revenue Forecast and Analysis
6.2 Global Immunodiagnostics Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Immunodiagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis

10.1 North America: Immunodiagnostics Market
10.1.1 Overview
10.1.2 North America: Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.3.1 North America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.4 North America: Immunodiagnostics Market, by Clinical Indication - 2020-2030 (US$ Million)
10.1.4.1 North America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.4.2 North America: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.5 North America: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.5.1 US: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.5.1.3.1 US: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4 US: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.1 US: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.2 US: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.5 US: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.5.2 Canada: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.5.2.3.1 Canada: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4 Canada: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.1 Canada: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.2 Canada: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.5 Canada: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.5.3 Mexico: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.1.5.3.3.1 Mexico: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4 Mexico: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.1 Mexico: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.2 Mexico: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.5 Mexico: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2 Europe: Immunodiagnostics Market
10.2.1 Overview
10.2.2 Europe: Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.3.1 Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.4 Europe: Immunodiagnostics Market, by Clinical Indication - 2020-2030 (US$ Million)
10.2.4.1 Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.4.2 Europe: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5 Europe: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.1 UK: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.1 Overview
10.2.5.1.2 UK: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.3 UK: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.1.3.1 UK: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4 UK: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.1 UK: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.2 UK: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.5 UK: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.2 Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.1 Overview
10.2.5.2.2 Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.3 Germany: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.2.3.1 Germany: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4 Germany: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.1 Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.2 Germany: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.5 Germany: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.3 France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.1 Overview
10.2.5.3.2 France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.3 France: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.3.3.1 France: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4 France: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.1 France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.2 France: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.5 France: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.4 Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.1 Overview
10.2.5.4.2 Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.3 Italy: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.4.3.1 Italy: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4 Italy: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.1 Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.2 Italy: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.5 Italy: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.5 Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.1 Overview
10.2.5.5.2 Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.3 Spain: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.5.3.1 Spain: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4 Spain: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.1 Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.2 Spain: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.5 Spain: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.2.5.6 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.1 Overview
10.2.5.6.2 Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.3 Rest of Europe: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.2.5.6.3.1 Rest of Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4 Rest of Europe: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.1 Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.2 Rest of Europe: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.5 Rest of Europe: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3 Asia Pacific: Immunodiagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.3.1 Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.4 Asia Pacific: Immunodiagnostics Market, by Clinical Indication - 2020-2030 (US$ Million)
10.3.4.1 Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.4.2 Asia Pacific: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5 Asia Pacific: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.1 China: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.1 Overview
10.3.5.1.2 China: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.3 China: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.1.3.1 China: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4 China: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.1 China: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.2 China: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.5 China: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.2 Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.1 Overview
10.3.5.2.2 Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.3 Japan: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.2.3.1 Japan: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4 Japan: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.1 Japan: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.2 Japan: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.5 Japan: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.3 India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.1 Overview
10.3.5.3.2 India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.3 India: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.3.3.1 India: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4 India: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.1 India: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.2 India: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.5 India: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.4 Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.1 Overview
10.3.5.4.2 Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.3 Australia: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.4.3.1 Australia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4 Australia: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.1 Australia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.2 Australia: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.5 Australia: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.5 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.1 Overview
10.3.5.5.2 South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.3 South Korea: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.5.3.1 South Korea: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4 South Korea: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.1 South Korea: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.2 South Korea: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.5 South Korea: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.3.5.6 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.1 Overview
10.3.5.6.2 Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.3 Rest of Asia Pacific: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.3.5.6.3.1 Rest of Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4 Rest of Asia Pacific: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.1 Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.2 Rest of Asia Pacific: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.5 Rest of Asia Pacific: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.4 Middle East & Africa: Immunodiagnostics Market
10.4.1 Overview
10.4.2 Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.4.3.1 Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.4.4 Middle East & Africa: Immunodiagnostics Market, by Clinical Indication - 2020-2030 (US$ Million)
10.4.4.1 Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.4.4.2 Middle East & Africa: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.4.5 Middle East & Africa: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.4.5.1 UAE: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 UAE: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.4.5.1.3.1 UAE: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4 UAE: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.1 UAE: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.2 UAE: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.5 UAE: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.4.5.2 Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.4.5.3 South Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 South Africa: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.4.5.3.3.1 South Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4 South Africa: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.1 South Africa: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.2 South Africa: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.5 South Africa: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.5 South & Central America: Immunodiagnostics Market
10.5.1 Overview
10.5.2 South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.5.3.1 South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.5.4 South & Central America: Immunodiagnostics Market, by Clinical Indication - 2020-2030 (US$ Million)
10.5.4.1 South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.5.4.2 South & Central America: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.5.5 South & Central America: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.5.5.1 Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.1 Overview
10.5.5.1.2 Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.3 Brazil: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.5.5.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4.1 Brazil: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4.2 Brazil: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.5 Brazil: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.5.5.2 Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.1 Overview
10.5.5.2.2 Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.3 Argentina: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.5.5.2.3.1 Argentina: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4 Argentina: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4.1 Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4.2 Argentina: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.5 Argentina: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
10.5.5.3 Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.1 Overview
10.5.5.3.2 Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.3 Rest of South & Central America: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
10.5.5.3.3.1 Rest of South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4 Rest of South & Central America: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4.1 Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4.2 Rest of South & Central America: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.5 Rest of South & Central America: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)

11. Impact Of COVID-19 Pandemic on Immunodiagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Global Immunodiagnostics Market -Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Immunodiagnostics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DiaSorin SpA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PerkinElmer Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Svar Life Science AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Siemens Healthcare GmbH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About the Publisher
14.2 Glossary of Terms

List of Tables

Table 1. Infectious Diseases and Funding
Table 2. North America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. US Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 10. US Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 11. US Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 12. US Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 13. US Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 32. UK Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 38. Germany Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 39. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 44. France Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 45. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 46. France Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 47. France: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 48. France Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 49. France Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 62. Rest of Europe Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 63. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 68. Asia Pacific Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 74. China Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 75. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 76. China Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 77. China Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 78. China Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 79. China Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 86. India Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 87. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 88. India Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 89. India: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 90. India Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 91. India Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 99. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 103. South Korea Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Asia Pacific Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 110. Middle East & Africa Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 116. UAE Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 117. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 118. UAE Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 119. UAE Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 120. UAE Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 121. UAE Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 124. Saudi Arabia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 125. Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 126. Saudi Arabia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 127. Saudi Arabia Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 128. South Africa Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 129. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of Middle East & Africa Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 140. South & Central America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 141. South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 146. Brazil Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 147. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 152. Argentina Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 153. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 158. Rest of South & Central America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 159. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 164. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 165. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 166. Glossary of Terms, Immunodiagnostics Market

List of Figures

Figure 1. Immunodiagnostics Market Segmentation
Figure 2. Immunodiagnostics Market, by Region
Figure 3. Global Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Immunodiagnostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Immunodiagnostics Market, by Geography (US$ Million)
Figure 7. Global Immunodiagnostics Market - Leading Country Markets (US$ Million)
Figure 8. Global Immunodiagnostics Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 17. Global Immunodiagnostics Market, by Geography - Forecast and Analysis (2020-2028)
Figure 18. Market Positioning of Key Players in Immunodiagnostics Market
Figure 19. Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 20. Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 29. Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 33. Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Gastrointestinal: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 42. Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 43. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 44. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 45. Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 46. Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 47. Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 49. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 50. Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 51. Hospitals: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 52. Clinics: Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 53. Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 54. Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 55. Others: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 56. North America: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 57. North America Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. North America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 59. US: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 60. Canada: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 61. Mexico: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 62. Europe: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 63. Europe Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 65. UK: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 66. Germany: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 67. France: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 68. Italy: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 69. Spain: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 70. Rest of Europe: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 71. Asia Pacific: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 72. Asia Pacific Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 74. China: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 75. Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 76. India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 77. Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 78. South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 79. Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 80. Middle East & Africa: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 81. Middle East & Africa Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 82. Middle East & Africa: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 83. UAE: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 84. Saudi Arabia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 85. South Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 86. Rest of Middle East & Africa: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 87. South & Central America: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 88. South & Central America Immunodiagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 89. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 90. Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 91. Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 92. Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 93. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 94. Impact of COVID-19 Pandemic on European Countries Markets
Figure 95. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 96. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 97. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 98. Growth Strategies in the Immunodiagnostics Market

Companies Mentioned

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corporation
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co Ltd
bioMerieux SA
Svar Life Science AB
Siemens Healthineers AG.

Table Information

Report Attribute	Details
No. of Pages	270
Published	July 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 19.22 Billion
Forecasted Market Value ( USD ) by 2030	$ 34.49 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3126EUR$3,185USD£2,613GBP €4466EUR$4,550USD£3,733GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4500EUR$4,585USD£3,762GBP €6429EUR$6,550USD£5,375GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5875EUR$5,985USD£4,911GBP €8392EUR$8,550USD£7,016GBP

Immunodiagnostics Market: Competitive Landscape and Key Developments

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2024-2032

Immunodiagnostics Market Report and Forecast 2024-2032

Immunodiagnostics Global Market Opportunities and Strategies to 2033

Immunodiagnostics Global Market Report 2024

Botulinum Immunodiagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)